Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Closed-Loop Transcranial Alternating Current Stimulation (CL-tACS) for the Treatment of Major Depressive Disorder: Double-Blind, Sham-Controlled Randomized Pilot Study

NCT06874374 is registered in ClinicalTrials.gov with Pulvinar Neuro, LLC as lead sponsor.

NCT NCT06874374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06874374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Closed-Loop Transcranial Alternating Current Stimulation (CL-tACS) for the Treatment of Major Depressive Disorder: Double-Blind, Sham-Controlled Randomized Pilot Study
Lead sponsor
Pulvinar Neuro, LLC
Phase
Not applicable
Overall status
Completed
Start date
April 11, 2025
Completion date
May 22, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, transcranial alternating current stimulation